Evidence map›Paper›PMID 42282718›Full record

ArticlebioRxiv : the preprint server for biology2026

ProNotch converts extracellular protease activity into programmable transcriptional outputs.

Jeremy C Tran, Christopher J Kuffner, Aiden C Reilly, Quan Le, John T Ngo

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeremy C TranDepartment of Biomedical Engineering, Biological Design Center, and Center for Multiscale Translational and Mechanobiology, Boston University, Boston, MA 02138.ORCID 0000-0001-6692-5899
Christopher J KuffnerDepartment of Biomedical Engineering, Biological Design Center, and Center for Multiscale Translational and Mechanobiology, Boston University, Boston, MA 02138.ORCID 0000-0002-4379-677X
Aiden C ReillyDepartment of Biomedical Engineering, Biological Design Center, and Center for Multiscale Translational and Mechanobiology, Boston University, Boston, MA 02138.ORCID 0009-0004-9117-4379
Quan LeDepartment of Biomedical Engineering, Biological Design Center, and Center for Multiscale Translational and Mechanobiology, Boston University, Boston, MA 02138.ORCID 0000-0002-9712-328X
John T NgoDepartment of Biomedical Engineering, Biological Design Center, and Center for Multiscale Translational and Mechanobiology, Boston University, Boston, MA 02138.ORCID 0000-0003-3508-1915

Funding

TRAINING PROGRAM IN QUANTITATIVE BIOLOGY AND PHYSIOLOGYT32GM008764 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI WHITE, JOHN A. · 2001 to 2021
$5.9M
Integrative Approaches for Probing Cell Mechanotransduction in Health and DiseaseR35GM128859 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI John Tuan Ngo · 2018 to 2026
$3.3M
NIGMS NIH HHS R35 GM128859NIGMS NIH HHS T32 GM008764
6 · The paper itself

Abstract

Synthetic receptors that convert extracellular protease activity into programmable transcriptional outputs would expand the toolkit of mammalian cell biology and cell engineering, yet modular platforms for directly coupling extracellular proteolysis to gene expression remain limited. Here we introduce ProNotch, a receptor architecture that harnesses protease-gated derepression of a mutant Notch1 negative regulatory region (NRR) to drive user-defined gene expression. ProNotch tethers destabilized NRR mutants to inhibitory anti-NRR single-chain variable fragments (scFvs) via protease-cleavable linkers. NRR engagement by high-affinity scFvs simultaneously rescues surface trafficking of mutant receptors and suppresses basal signaling until linker cleavage releases the inhibitory scFv module, permitting the destabilized NRR to initiate ligand-independent signaling. Linker substitution reprogrammed protease specificity across diverse enzymes, and tandem substrate repeats enhanced sensitivity without increasing basal activity. Single-chain receptor designs enabled OR and AND logic gates, allowing integration of multi-protease inputs into a single transcriptional output. ProNotch detected endogenous MMP-14 activity from cancer cell lines in

Identifiers

PMID42282718
PMCPMC13251938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.